Evidence map›Paper›PMID 36290315›Full record

ArticleBiology2022

CiberAMP: An

Rubén Caloto, L Francisco Lorenzo-Martín, Víctor Quesada, Arkaitz Carracedo, Xosé R Bustelo

Abstract read
In one paragraph

Article in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rubén CalotoMolecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007 Salamanca, Spain.
L Francisco Lorenzo-MartínMolecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0003-4717-9338
Víctor QuesadaCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0002-8398-3457
Arkaitz CarracedoCentro de Investigación Biomédica en Red de Cáncer (CIBERONC), CSIC-University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-5957-1260
Xosé R BusteloMolecular Mechanisms of Cancer Program, Centro de Investigación del Cáncer, CSIC-University of Salamanca, 37007 Salamanca, Spain.ORCID 0000-0001-9398-6072

Funding

Agencia Estatal de Investigacion, Spain RTI2018-096481-B-100Junta de Castilla y León CLC-2017-01Junta de Castilla y León CSI145P20Junta de Castilla y León CSI252P18Ministerio de Ciencia e Innovación, Spain BES-2016-0077909Ministerio de Educación, Cultura y Deportes FPU13/02923"La Caixa" Foundation HR20-00164
6 · The paper itself

Abstract

Somatic copy number variations (SCNVs) are genetic alterations frequently found in cancer cells. These genetic alterations can lead to concomitant perturbations in the expression of the genes included in them and, as a result, promote a selective advantage to cancer cells. However, this is not always the case. Due to this, it is important to develop in silico tools to facilitate the accurate identification and functional cataloging of gene expression changes associated with SCNVs from pan-cancer data. Here, we present a new

Indexed as

gene expressionglioblastomapan-cancerRNA sequencingsoftwaretranscriptome

Identifiers

PMID36290315
PMCPMC9598370

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.